Clinical Trial Update: Efficacy and Safety of Rivaroxiban Compare With Vitamin K Antagonist Warfarin [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rivaroxiban with warfarin for mitral valve stenosis and atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Mitral Valve Stenosis

Drugs mentioned

• Warfarin (warfarin)
• rivaroxiban (rivaroxaban)

Snippet

Sponsor: PharmEvo Pvt Ltd | Conditions: Mitral Valve Stenosis, Atrial Fibrillation | Phase 4 | Status: WITHDRAWN